|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 2401 to 2500 out of 5471 for Tyr

0.024s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Genotype
Symbol: Cdkn2a/Cdkn2a Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Kras/Kras<+> Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S4/SvJae * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Ckap5/Ckap5
Background: FVB/N-Ckap5
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Cks2/Cks2
Background: FVB/N-Cks2
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Cramp1/Cramp1
Background: involves: C57BL/6 * FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Cript/Cript
Background: involves: C57BL/6 * FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Dgka/Dgka
Background: FVB/N-Dgka
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Dhx29/Dhx29
Background: FVB/N-Dhx29
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Dync1h1/Dync1h1
Background: FVB/N-Dync1h1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Gtf3c1/Gtf3c1
Background: FVB/N-Gtf3c1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Ift52/Ift52
Background: FVB/N-Ift52
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Ipo9/Ipo9
Background: FVB/N-Ipo9
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Lcmt1/Lcmt1
Background: FVB/N-Lcmt1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Ndufv2/Ndufv2
Background: involves: C57BL/6 * FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Pcgf3/Pcgf3
Background: FVB/N-Pcgf3
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Pfdn2/Pfdn2
Background: FVB/N-Pfdn2
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Phf5a/Phf5a
Background: FVB/N-Phf5a
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Pot1b/Pot1b
Background: FVB/N-Pot1b
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Prkg1/Prkg1
Background: involves: FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Raf1/Raf1
Background: FVB/N-Raf1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rttn/Rttn
Background: FVB/N-Rttn
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Sf3a1/Sf3a1
Background: FVB/N-Sf3a1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Skic2/Skic2
Background: FVB/N-Skic2
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Slmap/Slmap
Background: involves: C57BL/6 * FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Snrnp200/Snrnp200
Background: FVB/N-Snrnp200
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Stag3/Stag3
Background: FVB/N-Stag3
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Tapt1/Tapt1
Background: FVB/N-Tapt1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Ubap2l/Ubap2l
Background: FVB/N-Ubap2l
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Acly/Acly
Background: FVB/N-Acly
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Ap2b1/Ap2b1
Background: FVB/N-Ap2b1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Cbfb/Cbfb
Background: FVB/N-Cbfb
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Chchd3/Chchd3
Background: FVB/N-Chchd3
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rnf41/Rnf41
Background: involves: C57BL/6 * FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: In(10C1;Ccdc53)4Ove/In(10C1;Ccdc53)4Ove
Background: involves: FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: In(15Rictor;Slc1a3)1Ove/In(15Rictor;Slc1a3)1Ove
Background: involves: FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: In(18E2;Smad4)3Ove/In(18E2;Smad4)3Ove
Background: involves: FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: In(6Exoc4)2Ove/In(6Exoc4)2Ove
Background: involves: FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Dcaf1/Dcaf1
Background: FVB/N-Dcaf1
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Vps13d/Vps13d
Background: FVB/N-Vps13d
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Wdr19/Wdr19
Background: FVB/N-Wdr19
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/? TgTn(sb-T2/Onc)#Dla/?
Background: involves: 129S6/SvEvTac * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Sox10/Sox10<+> Tg(Tyr-cre/ERT2)13Bos/? Tg(Tyr-NRAS*Q61K)1Bee/?
Background: involves: 129P2/OlaHsd * C57BL/6J * DBA/2 * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/? Tg(Tyr-NRAS*Q61K)1Bee/?
Background: FVB.Cg-Tg(Tyr-cre/ERT2)13Bos Trp53 Tg(Tyr-NRAS*Q61K)1Bee
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: C3FeJ.Cg-Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor/Cvrk
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Cdkn2a Kras
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf<+> Pten/Pten Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S1/Sv * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf<+> Pten/Pten Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf<+> Pten/Pten<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S1/Sv * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Tg(Tyr-Ctnnb1/EGFP)#Lru/?
Background: B6.Cg-Tg(Tyr-Ctnnb1/EGFP)#Lru
Zygosity: ot
Has Mutant Allele: true
Genotype
Symbol: Tg(Dct-lacZ)A12Jkn/? Tg(Tyr-Ctnnb1/EGFP)#Lru/?
Background: B6.Cg-Tg(Tyr-Ctnnb1/EGFP)#Lru Tg(Dct-lacZ)A12Jkn
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Ednrb/Ednrb Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Ednrb/Ednrb Tg(Dct-lacZ)#Ove/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Mc1r/Mc1r Tg(Dct-lacZ)#Ove/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pikfyve/Pikfyve Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: C57BL/6 * C57BL/6J
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129 * 129S4/SvJae * 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Ins2/Ins2 Jazf1/Jazf1 Tg(Ins2-cre)23Herr/?
Background: involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S4/SvJaeSor * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: B6.Cg-Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor
Zygosity: cn
Has Mutant Allele: true
Publication  
First Author: Persson B
Year: 2003
Journal: Chem Biol Interact
Title: Coenzyme-based functional assignments of short-chain dehydrogenases/reductases (SDRs).
Volume: 143-144
Pages: 271-8
Publication  
First Author: Oppermann U
Year: 2003
Journal: Chem Biol Interact
Title: Short-chain dehydrogenases/reductases (SDR): the 2002 update.
Volume: 143-144
Pages: 247-53
Publication
First Author: Neidle EL
Year: 1991
Journal: J Bacteriol
Title: Nucleotide sequences of the Acinetobacter calcoaceticus benABC genes for benzoate 1,2-dioxygenase reveal evolutionary relationships among multicomponent oxygenases.
Volume: 173
Issue: 17
Pages: 5385-95
Publication
First Author: Hijarrubia MJ
Year: 2001
Journal: Mol Gen Genet
Title: Characterization of the lys2 gene of Acremonium chrysogenum encoding a functional alpha-aminoadipate activating and reducing enzyme.
Volume: 264
Issue: 6
Pages: 755-62
Publication
First Author: Silakowski B
Year: 2000
Journal: Eur J Biochem
Title: The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15.
Volume: 267
Issue: 21
Pages: 6476-85
Publication
First Author: Kavanagh KL
Year: 2008
Journal: Cell Mol Life Sci
Title: Medium- and short-chain dehydrogenase/reductase gene and protein families : the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes.
Volume: 65
Issue: 24
Pages: 3895-906
Publication
First Author: Deacon AM
Year: 2000
Journal: Structure
Title: The crystal structure of ADP-L-glycero-D-mannoheptose 6-epimerase: catalysis with a twist.
Volume: 8
Issue: 5
Pages: 453-62
Publication
First Author: Ding L
Year: 1999
Journal: Acta Crystallogr D Biol Crystallogr
Title: Crystallization and preliminary X-ray diffraction studies of the lipopolysaccharide core biosynthetic enzyme ADP-L-glycero-D-mannoheptose 6-epimerase from Escherichia coli K-12.
Volume: 55
Issue: Pt 3
Pages: 685-8
Publication
First Author: Heatwole VM
Year: 1991
Journal: J Bacteriol
Title: Cloning, nucleotide sequence, and characterization of mtr, the structural gene for a tryptophan-specific permease of Escherichia coli K-12.
Volume: 173
Issue: 1
Pages: 108-15
Publication
First Author: Sarsero JP
Year: 1991
Journal: J Bacteriol
Title: A new family of integral membrane proteins involved in transport of aromatic amino acids in Escherichia coli.
Volume: 173
Issue: 10
Pages: 3231-4
Publication  
First Author: Felices M
Year: 2007
Journal: Adv Immunol
Title: Tec kinases in T cell and mast cell signaling.
Volume: 93
Pages: 145-84
Protein Domain
Type: Domain
Description: This domain includes the C-terminal domain from the fungal alpha aminoadipate reductase enzyme (also known as aminoadipate semialdehyde dehydrogenase) which is involved in the biosynthesis of lysine [], as well as the reductase-containing component of the myxochelin biosynthetic gene cluster, MxcG []. The mechanism of reduction involves activation of the substrate by adenylation and transfer to a covalently-linked pantetheine cofactor as a thioester. This thioester is then reduced to give an aldehyde (thus releasing the product) and a regenerated pantetheine thiol []; in myxochelin biosynthesis this aldehyde is further reduced to an alcohol or converted to an amine by an aminotransferase. This is a fundamentally different reaction than beta-ketoreductase domains of polyketide synthases which act at a carbonyl two carbons removed from the thioester and forms an alcohol as a product. The majority of bacterial sequences containing this domain are non-ribosomal peptide synthetases in which this domain is similarly located proximal to a thiolation domain. In some cases this domain is found at the end of a polyketide synthetase enzyme, but is unlike ketoreductase domains which are found before the thiolase domains. Exceptions to this observed relationship with the thiolase domain include three proteins which consist of stand-alone reductase domains (from Mycobacterium leprae, Anabaena and from Streptomyces coelicolor) and one protein (from Nostoc) which contains N-terminal homology with a small group of hypothetical proteins but no evidence of a thiolation domain next to the putative reductase domain.This family consists of a short-chain dehydrogenase/reductase (SDR) module of multidomain proteins identified as putative polyketide sythases fatty acid synthases (FAS), and nonribosomal peptide synthases, among others. However, unlike the usual ketoreductase modules of FAS and polyketide synthase, these domains are related to the extended SDRs, and have canonical NAD(P)-binding motifs and an active site tetrad. Extended short-chain dehydrogenases/reductases (SDRs) are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central β-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG].XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif [, , , , , , , ].
Protein Domain
Type: Family
Description: Lipopolysaccharides (LPS) are glycolipids that consitutes the outer monolayer of the outer membranes of most Gram-negative bacteria []. They consist of lipid A (endotoxin) which anchors LPS to the outer membrane, a non-repeating core oligosachharide, and an immunogenic O-antigen repeat polymer, which is an oligosaccharide of 1-40 units that variesbetween different strains of bacteria. Although the O-antigen and most of the core domain are not necessary for growth in the lab, they appear to help bacteria resist environmental stresses including the complement system and antibiotics.This family consists of examples of ADP-L-glycero-D-mannoheptose-6-epimerase, an enzyme involved in biosynthesis of the inner core of LPS in Gram-negative bacteria []. This enzyme is homologous to UDP-glucose 4-epimerase () and belongs to the NAD dependent epimerase/dehydratase family. It participates in the biosynthetic pathway leading to incorporation of heptose, a conserved sugar, into the core region of LPS, performing the NAD-dependent reaction shown below:ADP-D-glycero-D-manno-heptose = ADP-L-glycero-D-manno-heptoseIt is a homopentameric enzyme with each monomer composed of two domains: an N-terminal modified Rossman fold domain for NADP binding, and a C-terminal substrate binding domain. This subgroup has the canonical active site tetrad and NAD(P)-binding motif [].Extended short-chain dehydrogenases/reductases (SDRs) are distinct from classical SDRs. In addition to the Rossmann fold (alpha/beta folding pattern with a central β-sheet) core region typical of all SDRs, extended SDRs have a less conserved C-terminal extension of approximately 100 amino acids. Extended SDRs are a diverse collection of proteins, and include isomerases, epimerases, oxidoreductases, and lyases; they typically have a TGXXGXXG cofactor binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold, an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Sequence identity between different SDR enzymes is typically in the 15-30% range; they catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG].XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase numbering). In addition to the Tyr and Lys, there is often an upstream Ser and/or an Asn, contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Atypical SDRs generally lack the catalytic residues characteristic of the SDRs, and their glycine-rich NAD(P)-binding motif is often different from the forms normally seen in classical or extended SDRs. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif [, , , , , , , ].
Publication
First Author: Ladenstein R
Year: 2008
Journal: Cell Mol Life Sci
Title: Medium- and short-chain dehydrogenase/reductase gene and protein families : Structure-function relationships in short-chain alcohol dehydrogenases.
Volume: 65
Issue: 24
Pages: 3918-35
Publication
First Author: Kallberg Y
Year: 2010
Journal: FEBS J
Title: Classification of the short-chain dehydrogenase/reductase superfamily using hidden Markov models.
Volume: 277
Issue: 10
Pages: 2375-86
Publication
First Author: Persson B
Year: 2009
Journal: Chem Biol Interact
Title: The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative.
Volume: 178
Issue: 1-3
Pages: 94-8
Publication
First Author: Bray JE
Year: 2009
Journal: Chem Biol Interact
Title: The human short-chain dehydrogenase/reductase (SDR) superfamily: a bioinformatics summary.
Volume: 178
Issue: 1-3
Pages: 99-109
Publication
First Author: Schenk G
Year: 1999
Journal: Arch Biochem Biophys
Title: Binuclear metal centers in plant purple acid phosphatases: Fe-Mn in sweet potato and Fe-Zn in soybean.
Volume: 370
Issue: 2
Pages: 183-9
Publication
First Author: Kosaka Y
Year: 2006
Journal: Trends Immunol
Title: Itk and Th2 responses: action but no reaction.
Volume: 27
Issue: 10
Pages: 453-60
Publication
First Author: Fischer AM
Year: 2004
Journal: J Biol Chem
Title: Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase ITK.
Volume: 279
Issue: 28
Pages: 29816-20
Publication
First Author: Adorno M
Year: 2013
Journal: Nature
Title: Usp16 contributes to somatic stem-cell defects in Down's syndrome.
Volume: 501
Issue: 7467
Pages: 380-4
Publication
First Author: Griess K
Year: 2023
Journal: Nat Cell Biol
Title: Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis.
Volume: 25
Issue: 1
Pages: 20-29
Publication
First Author: Chen S
Year: 2017
Journal: Nature
Title: Palmitoylation-dependent activation of MC1R prevents melanomagenesis.
Volume: 549
Issue: 7672
Pages: 399-403
Publication  
First Author: Trigg MJ
Year: 1972
Journal: J Zool
Title: Hair growth in mouse mutants affecting coat texture.
Volume: 168
Pages: 165-198
Publication  
First Author: KOCHER W
Year: 1960
Journal: Z Vererbungsl
Title: [Studies on the genetics and pathology of the development of 8 labyrinth mutants (deaf-waltzer-shaker mutants) in the mouse (Mus musculus)].
Volume: 91
Pages: 114-40
Publication
First Author: Levy C
Year: 2010
Journal: Cell
Title: Lineage-specific transcriptional regulation of DICER by MITF in melanocytes.
Volume: 141
Issue: 6
Pages: 994-1005
Publication
First Author: Sharma S
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Volume: 117
Issue: 14
Pages: 8001-8012
Publication
First Author: Jean P
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Intrinsic planar polarity mechanisms influence the position-dependent regulation of synapse properties in inner hair cells.
Volume: 116
Issue: 18
Pages: 9084-9093
Publication
First Author: McGrath J
Year: 2021
Journal: Curr Biol
Title: Actin at stereocilia tips is regulated by mechanotransduction and ADF/cofilin.
Volume: 31
Issue: 6
Pages: 1141-1153.e7
Publication
First Author: Prosser HM
Year: 2008
Journal: Mol Cell Biol
Title: Mosaic complementation demonstrates a regulatory role for myosin VIIa in actin dynamics of stereocilia.
Volume: 28
Issue: 5
Pages: 1702-12
Publication
First Author: Brehm MA
Year: 2010
Journal: Diabetes
Title: Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.
Volume: 59
Issue: 9
Pages: 2265-70
Publication
First Author: Pearson T
Year: 2008
Journal: Diabetologia
Title: A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.
Volume: 51
Issue: 8
Pages: 1449-56
Publication
First Author: Nagareddy PR
Year: 2013
Journal: Cell Metab
Title: Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
Volume: 17
Issue: 5
Pages: 695-708
Publication
First Author: Lee EK
Year: 2013
Journal: Mol Cell Biol
Title: The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.
Volume: 33
Issue: 22
Pages: 4422-33
Publication
First Author: Mori KP
Year: 2017
Journal: J Am Soc Nephrol
Title: Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy.
Volume: 28
Issue: 1
Pages: 278-289
Publication
First Author: Hathaway CK
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice.
Volume: 112
Issue: 18
Pages: 5815-20